Clear-cell adenocarcinoma of the vagina

Clear-cell adenocarcinoma of the vagina is a rare form of vaginal cancer that primarily affects young women and girls. This type of cancer is characterized by the presence of clear cells, which are a type of cell that can be seen under a microscope.

Etiology

The exact cause of clear-cell adenocarcinoma of the vagina is unknown. However, it has been associated with prenatal exposure to diethylstilbestrol (DES), a synthetic form of the hormone estrogen that was prescribed to prevent miscarriages and premature births between 1940 and 1971. Women whose mothers took DES during pregnancy have a higher risk of developing this type of cancer.

Symptoms

Symptoms of clear-cell adenocarcinoma of the vagina can vary, but may include abnormal vaginal bleeding or discharge, pain during sexual intercourse, and a palpable mass in the vagina. However, many women with this type of cancer do not experience any symptoms until the disease has advanced.

Diagnosis

Diagnosis of clear-cell adenocarcinoma of the vagina typically involves a physical examination, a Pap test, and a biopsy of any abnormal tissue. Imaging tests such as a CT scan or MRI may also be used to determine the extent of the cancer.

Treatment

Treatment for clear-cell adenocarcinoma of the vagina typically involves surgery to remove the cancer, followed by radiation therapy or chemotherapy to kill any remaining cancer cells. The specific treatment plan will depend on the stage of the cancer and the patient's overall health.

Prognosis

The prognosis for clear-cell adenocarcinoma of the vagina depends on a number of factors, including the stage of the cancer at diagnosis, the patient's overall health, and the effectiveness of treatment. Early detection and treatment can improve the prognosis.

See also

• Vaginal cancer
• Diethylstilbestrol
• Pap test
• CT scan
• MRI

‎